 |
| Opinion |  Top |
|
 |
|
| Editorials |
|
|
|
Gene therapy: The US FTC explains it all to you p109
doi:10.1038/nbt0297-109a
PDF
(143K)
|
|
|
|
Miami Winter Symposium gets back to basics p109
doi:10.1038/nbt0297-109b
PDF
(143K)
|
|
 |
|
| Commentary |
|
|
|
Biotechnology, bioremediation, and blue genes p110
Harvey Bialy
doi:10.1038/nbt0297-110
PDF
(155K)
|
|
|
|
The end of big government? p111
Henry I. Miller
doi:10.1038/nbt0297-111
PDF
(168K)
|
|
|
|
Genetically enhanced food for thought p112
Edward S. Golub
doi:10.1038/nbt0297-112
PDF
(167K)
|
|
| In Brief | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Business & Regulatory News pp113 - 116
doi:10.1038/nbt0297-113
PDF
(751K)
|
|
| Analysis | Top |
|
|
|
| Business and Regulatory News |
|
|
|
GI−AHP deal may catalyze more big—time acquisitions pp117 - 118
Vicki Brower
doi:10.1038/nbt0297-117
PDF
(370K)
|
|
|
|
Novartis licenses gene therapy to avoid monopoly pp118 - 119
Vicki Glaser
doi:10.1038/nbt0297-118
PDF
(369K)
|
|
|
|
EC−FDA mutual recognition agreement proves difficult pp119 - 120
John Hodgson
doi:10.1038/nbt0297-119
PDF
(411K)
|
|
|
|
"Ganske" threatens biotechnology patents worldwide p121
Vicki Glaser
doi:10.1038/nbt0297-121a
PDF
(142K)
|
|
|
|
Genomics companies welcome US PTO initiative on DMA patents pp121 - 122
Andrew Marshall
doi:10.1038/nbt0297-121b
PDF
(438K)
|
|
|
|
| Research News |
|
|
|
Reflections on internal images pp123 - 124
Neil S. Greenspan
doi:10.1038/nbt0297-123
References | PDF
(324K)
|
|
|
|
Tipping the balance of blood coagulation pp124 - 125
Brian W. Grinnell
doi:10.1038/nbt0297-124
References | PDF
(281K)
|
|
|
|
Mix and match: Building manifold binding sites pp125 - 126
Hennie R. Hoogenboom
doi:10.1038/nbt0297-125
References | PDF
(301K)
|
|
|
|
Phytoremediation: A clean transition from laboratory to marketplace? pp127 - 128
George E. Boyajian
& Laura H. Carreira
doi:10.1038/nbt0297-127
References | PDF
(388K)
|
|
|
|
Carboxypeptidase E: A surprise player in protein sorting pp128 - 129
James Kling
doi:10.1038/nbt0297-128
PDF
(286K)
|
|
| Feature | Top |
|
|
|
Approval times for supplemental indications for recombinant proteins pp130 - 134
Marilyn E. Gosse
& Toben F. Nelson
doi:10.1038/nbt0297-130
Abstract + references | PDF
(870K)
|
|
| In Brief | Top |
|
|
|
Nature Biotechnology Research p135
doi:10.1038/nbt0297-135
PDF
(290K)
|
|
| Research Review | Top |
|
|
|
Transgenic plants: An emerging approach to pest control pp137 - 141
Juan J. Estruch, Nadine B. Carozzi, Nalini Desai, Nicholas B. Duck, Gregory W. Warren
& Michael G. Koziel
doi:10.1038/nbt0297-137
Abstract + references | PDF
(759K)
|
|
| Research Articles | Top |
|
|
|
A bioactive designer cytokine for human hematopoietic progenitor cell expansion pp142 - 145
Martina Fischer, Jutta Goldschmitt, Christian Peschel, Just P. G. Brakenhoff, Karl-Josef Kallen, Axel Wollmer, Joachim Grötzinger
& Stefan Rose-John
doi:10.1038/nbt0297-142
Abstract + references | PDF
(505K)
|
|
|
|
Rational engineering of activity and specificity in a serine protease pp146 - 149
Quoc D. Dang, Enriqueta R. Guinto
& Enrico Di Cera
doi:10.1038/nbt0297-146
Abstract + references | PDF
(490K)
|
|
|
|
Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes
pp150 - 154
Xin Zhang, Muriel Gaubin, Laurence Briant, Vasantha Srikantan, Ramachandran Murali, Uri Saragovi, David Weiner, Christian Devaux, Monica Autiero, Dominique Piatier-Tonneau
& Mark I. Greene
doi:10.1038/nbt0297-150
Abstract + references | PDF
(715K)
|
|
|
|
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity pp155 - 158
W. Magliani, S. Conti, F. De Bernardis, M. Gerloni, D. Bertolotti, P. Mozzoni, A. Cassone
& L. Polonelli
doi:10.1038/nbt0297-155
Abstract + references | PDF
(493K)
|
|
|
|
Design and production of novel tetravalent bispecific antibodies pp159 - 163
M. Josefina Coloma
& Sherie L. Morrison
doi:10.1038/nbt0297-159
Abstract + references | PDF
(587K)
|
|
|
|
Electrically induced NGF production by astroglial cells pp164 - 166
Sumihiro Koyama, Tetsuya Haruyama, Eiry Kobatake
& Masuo Aizawa
doi:10.1038/nbt0297-164
Abstract + references | PDF
(480K)
|
|
|
|
Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery pp167 - 173
Yong Liu, Leslie C. Mounkes, H. Denny Liggitt, Carolyn S. Brown, Igor Solodin, Timothy D. Heath
& Robert J. Debs
doi:10.1038/nbt0297-167
Abstract + references | PDF
(1,022K)
|
|
|
|
Plant cell biodegradation of a xenobiotic nitrate ester, nitroglycerin pp174 - 177
Akshay Goel, Guneet Kumar, Gregory F. Payne
& Shyam K. Dube
doi:10.1038/nbt0297-174
Abstract + references | PDF
(454K)
|
|
|
|
Phytoplasma induced free-branching in commercial poinsettia cultivars pp178 - 182
Ing-Ming Lee, Michael Klopmeyer, Irena M. Bartoszyk, Dawn E. Gundersen-Rindal, Tau-San Chou, Karen L. Thomson
& Robert Eisenreich
doi:10.1038/nbt0297-178
Abstract + references | PDF
(738K)
|
|
| Resources | Top |
|
|
|
| Patents |
|
|
|
Going beyond the native: Protecting DMA and protein patents pp183 - 185
Kenneth G. Chahine
doi:10.1038/nbt0297-183
Abstract + references | PDF
(277K)
|
|
|
|
Recent patent applications in the area of peptides p186
doi:10.1038/nbt0297-186
PDF
(271K)
|
|
|
|
| Book Review |
|
|
|
Differentiating data and information p187
John Hodgson
doi:10.1038/nbt0297-187
Abstract | PDF
(224K)
|
|
|
|
| WWW Guide |
|
|
|
Chromatography on the WWW p189
Richard Peters
& Robert S. Sikorski
doi:10.1038/nbt0297-189
PDF
(226K)
|
|
|
|
| People |
|
|
|
People p191
doi:10.1038/nbt0297-191
PDF
(139K)
|
|
|
|
| New Products |
|
|
|
New Products p192
doi:10.1038/nbt0297-192
PDF
(191K)
|
|
|
Top |
|
|
